Science 4 September 1992: Vol. 257. no. 5075, pp. 1401 - 1403 DOI: 10.1126/science.1382313

Prev | Table of Contents | Next

Articles

Human Studies of Angiogenic Gene Therapy.

R. Gupta, J. Tongers, and D. W. Losordo (2009)
Circ. Res. 105, 724-736
 |  Abstract »  |  Full Text »  |  PDF »

Cardioprotective growth factors.

D. J. Hausenloy and D. M. Yellon (2009)
Cardiovasc Res 83, 179-194
 |  Abstract »  |  Full Text »  |  PDF »

Vascular Regeneration by Local Growth Factor Release Is Self-Limited by Microvascular Clearance.

K. N. Le, C.-W. Hwang, A. R. Tzafriri, M. A. Lovich, A. Hayward, and E. R. Edelman (2009)
Circulation 119, 2928-2935
 |  Abstract »  |  Full Text »  |  PDF »

Vascular Regeneration by Repeated Infusions of Basic Fibroblast Growth Factor in a Rabbit Model of Hind-Limb Ischemia.

A. Seko, N. Nitta, A. Sonoda, S. Ohta, M. Takahashi, K. Murata, and Y. Tabata (2009)
Am. J. Roentgenol. 192, W306-W310
 |  Abstract »  |  Full Text »  |  PDF »

Novel approach with intratracheal administration of microgelatin hydrogel microspheres incorporating basic fibroblast growth factor for rescue of rats with monocrotaline-induced pulmonary hypertension..

K. Hirose, A. Marui, Y. Arai, T. Kushibiki, Y. Kimura, H. Sakaguchi, H. Yuang, B.I.R. S. Chandra, T. Ikeda, S. Amano, et al. (2008)
J. Thorac. Cardiovasc. Surg. 136, 1250-1256
 |  Abstract »  |  Full Text »  |  PDF »

Therapeutic Angiogenesis.

S. M. Vartanian and R. Sarkar (2007)
Vascular and Endovascular Surgery 41, 173-185
 |  Abstract »  |  PDF »

Local implantation of autologous mononuclear cells from bone marrow and peripheral blood for treatment of ischaemic digits in patients with connective tissue diseases.

Y. Kamata, Y. Takahashi, M. Iwamoto, K. Matsui, Y. Murakami, K. Muroi, U. Ikeda, K. Shimada, T. Yoshio, H. Okazaki, et al. (2007)
Rheumatology 46, 882-884
 |  Abstract »  |  Full Text »  |  PDF »

Repair of the damaged heart by bone marrow cells: from experimental evidence to clinical hope..

K.-L. Ang, L. Takura Shenje, L. Srinivasan, and M. Galinanes (2006)
Ann. Thorac. Surg. 82, 1549-1558
 |  Abstract »  |  Full Text »  |  PDF »

Effects of basic fibroblast growth factor on experimental diabetic neuropathy in rats..

M. Nakae, H. Kamiya, K. Naruse, N. Horio, Y. Ito, R. Mizubayashi, Y. Hamada, E. Nakashima, N. Akiyama, Y. Kobayashi, et al. (2006)
Diabetes 55, 1470-1477
 |  Abstract »  |  Full Text »  |  PDF »

FAK-dependent regulation of myofibroblast differentiation.

R. S. Greenberg, A. M. Bernstein, M. Benezra, I. H. Gelman, L. Taliana, and S. K. Masur (2006)
FASEB J 20, 1006-1008
 |  Abstract »  |  Full Text »  |  PDF »

Expression of Platelet-Derived Growth Factor and Fibroblast Growth Factor in Cryopreserved Endomyocardial Biopsies Early and Late After Heart Transplant.

A. Koch, E. Palchyk, N. Gassler, T. J. Dengler, A. Remppis, M. Pritsch, F.-U. Sack, S. Hagl, and P. A. Schnabel (2006)
Ann. Thorac. Surg. 81, 1372-1378
 |  Abstract »  |  Full Text »  |  PDF »

A free radical scavenger but not FGF-2-mediated angiogenic therapy rescues myonephropathic metabolic syndrome in severe hindlimb ischemia.

K. Kaneko, Y. Yonemitsu, T. Fujii, M. Onimaru, C.-H. Jin, M. Inoue, M. Hasegawa, T. Onohara, Y. Maehara, and K. Sueishi (2006)
Am J Physiol Heart Circ Physiol 290, H1484-H1492
 |  Abstract »  |  Full Text »  |  PDF »

Sustained-release form of basic fibroblast growth factor prevents catheter-related bacterial invasion in mice.

K. Hirose, A. Marui, Y. Arai, M. Fujita, T. Nomura, M. Mitsuyama, Y. Tabata, and M. Komeda (2005)
Interactive CardioVascular and Thoracic Surgery 4, 526-530
 |  Abstract »  |  Full Text »  |  PDF »

TRANSENDOCARDIAL AND TRANSEPICARDIAL INTRAMYOCARDIAL FIBROBLAST GROWTH FACTOR-2 ADMINISTRATION: MYOCARDIAL AND TISSUE DISTRIBUTION.

R. J. Laham, M. Post, M. Rezaee, L. Donnell-Fink, J. J. Wykrzykowska, S. U. Lee, D. S. Baim, and F. W. Sellke (2005)
Drug Metab. Dispos. 33, 1101-1107
 |  Abstract »  |  Full Text »  |  PDF »

Adenoviral Gene Transfer of FGF-5 to Hibernating Myocardium Improves Function and Stimulates Myocytes to Hypertrophy and Reenter the Cell Cycle.

G. Suzuki, T.-C. Lee, J. A. Fallavollita, and J. M. Canty Jr (2005)
Circ. Res. 96, 767-775
 |  Abstract »  |  Full Text »  |  PDF »

Dynamic Induction of ADAMTS1 Gene in the Early Phase of Acute Myocardial Infarction.

K. Nakamura, S. Hirohata, T. Murakami, T. Miyoshi, K. Demircan, T. Oohashi, H. Ogawa, K. Koten, K. Toeda, S. Kusachi, et al. (2004)
J. Biochem. 136, 439-446
 |  Abstract »  |  Full Text »  |  PDF »

Synergistic Effect of Bone Marrow Mobilization and Vascular Endothelial Growth Factor-2 Gene Therapy in Myocardial Ischemia.

A. Kawamoto, T. Murayama, K. Kusano, M. Ii, T. Tkebuchava, S. Shintani, A. Iwakura, I. Johnson, P. von Samson, A. Hanley, et al. (2004)
Circulation 110, 1398-1405
 |  Abstract »  |  Full Text »  |  PDF »

Collateralization and the response to obstruction of epicardial coronary arteries.

M.H. Tayebjee, G.Y.H. Lip, and R.J. MacFadyen (2004)
QJM 97, 259-272
 |  Abstract »  |  Full Text »  |  PDF »

Thromboxane A2 Receptor Agonists Antagonize the Proangiogenic Effects of Fibroblast Growth Factor-2: Role of Receptor Internalization, Thrombospondin-1, and {alpha}v{beta}3.

A. W. Ashton, Y. Cheng, A. Helisch, and J. A. Ware (2004)
Circ. Res. 94, 735-742
 |  Abstract »  |  Full Text »  |  PDF »

Low Molecular Weight Fucoidan and Heparin Enhance the Basic Fibroblast Growth Factor-Induced Tube Formation of Endothelial Cells through Heparan Sulfate-Dependent {alpha}6 Overexpression.

D. Chabut, A.-M. Fischer, S. Colliec-Jouault, I. Laurendeau, S. Matou, B. Le Bonniec, and D. Helley (2003)
Mol. Pharmacol. 64, 696-702
 |  Abstract »  |  Full Text »  |  PDF »

Toward surgical angiogenesis using slow-released basic fibroblast growth factor.

Y. Sakakibara, K. Tambara, G. Sakaguchi, F. Lu, M. Yamamoto, K. Nishimura, Y. Tabata, and M. Komeda (2003)
Eur. J. Cardiothorac. Surg. 24, 105-112
 |  Abstract »  |  Full Text »  |  PDF »

Angiographic Assessment of Collateral Connections in Comparison With Invasively Determined Collateral Function in Chronic Coronary Occlusions.

G. S. Werner, M. Ferrari, S. Heinke, F. Kuethe, R. Surber, B. M. Richartz, and H. R. Figulla (2003)
Circulation 107, 1972-1977
 |  Abstract »  |  Full Text »  |  PDF »

Low-Molecular-Weight Fucoidan Promotes Therapeutic Revascularization in a Rat Model of Critical Hindlimb Ischemia.

C.-E. Luyt, A. Meddahi-Pelle, B. Ho-Tin-Noe, S. Colliec-Jouault, J. Guezennec, L. Louedec, H. Prats, M.-P. Jacob, M. Osborne-Pellegrin, D. Letourneur, et al. (2003)
J. Pharmacol. Exp. Ther. 305, 24-30
 |  Abstract »  |  Full Text »

Growth factors improve latissimus dorsi muscle vascularization and trophicity after cardiomyoplasty.

G. Zakine, E. Martinod, P. Fornes, M. Sapoval, D. Barritault, A. F. Carpentier, and J. C. Chachques (2003)
Ann. Thorac. Surg. 75, 549-554
 |  Abstract »  |  Full Text »  |  PDF »

Biological activities of fibroblast growth factor-2 in the adult myocardium.

K. A. Detillieux, F. Sheikh, E. Kardami, and P. A. Cattini (2003)
Cardiovasc Res 57, 8-19
 |  Abstract »  |  Full Text »  |  PDF »

Biological Revascularization and the Interventional Molecular Cardiologist: Bypass for the Next Generation.

D. W. Losordo and A. Kawamoto (2002)
Circulation 106, 3002-3005
 |  Full Text »  |  PDF »

The combined use of transmyocardial laser revascularization (TMLR) and fibroblastic growth factor (FGF-2) enhances perfusion and regional contractility in chronically ischemic porcine hearts.

G. Lutter, T. Attmann, C. Heilmann, P. von Samson, B. von Specht, and F. Beyersdorf (2002)
Eur. J. Cardiothorac. Surg. 22, 753-761
 |  Abstract »  |  Full Text »  |  PDF »

Lack of alpha 2-antiplasmin promotes pulmonary heart failure via overrelease of VEGF after acute myocardial infarction.

H. Matsuno, O. Kozawa, N. Yoshimi, S. Akamatsu, A. Hara, H. Mori, K. Okada, S. Ueshima, O. Matsuo, and T. Uematsu (2002)
Blood 100, 2487-2493
 |  Abstract »  |  Full Text »  |  PDF »

Gene Transfer of Hepatocyte Growth Factor to Subarachnoid Space in Cerebral Hypoperfusion Model.

S.-i. Yoshimura, R. Morishita, K. Hayashi, J. Kokuzawa, M. Aoki, K. Matsumoto, T. Nakamura, T. Ogihara, N. Sakai, and Y. Kaneda (2002)
Hypertension 39, 1028-1034
 |  Abstract »  |  Full Text »  |  PDF »

Therapeutic angiogenesis induced by local autologous bone marrow cell implantation.

K. Hamano, T.-S. Li, T. Kobayashi, K. Hirata, M. Yano, M. Kohno, and M. Matsuzaki (2002)
Ann. Thorac. Surg. 73, 1210-1215
 |  Abstract »  |  Full Text »  |  PDF »

Exacerbation of myocardial injury in transgenic mice overexpressing FGF-2 is T cell dependent.

J. T. A. Meij, F. Sheikh, S. K. Jimenez, P. W. Nickerson, E. Kardami, and P. A. Cattini (2002)
Am J Physiol Heart Circ Physiol 282, H547-H555
 |  Abstract »  |  Full Text »  |  PDF »

Periodontal Regeneration by FGF-2 (bFGF) in Primate Models.

S. Takayama, S. Murakami, Y. Shimabukuro, M. Kitamura, and H. Okada (2001)
Journal of Dental Research 80, 2075-2079
 |  Abstract »  |  PDF »

Angiogenesis by endothelial cell transplantation.

E.-J. Kim, R.-K. Li, R. D. Weisel, D. A.G. Mickle, Z.-Q. Jia, S. Tomita, T. Sakai, and T. M. Yau (2001)
J. Thorac. Cardiovasc. Surg. 122, 963-971
 |  Abstract »  |  Full Text »  |  PDF »

Implantation of Bone Marrow Mononuclear Cells Into Ischemic Myocardium Enhances Collateral Perfusion and Regional Function via Side Supply of Angioblasts, Angiogenic Ligands, and Cytokines.

H. Kamihata, H. Matsubara, T. Nishiue, S. Fujiyama, Y. Tsutsumi, R. Ozono, H. Masaki, Y. Mori, O. Iba, E. Tateishi, et al. (2001)
Circulation 104, 1046-1052
 |  Abstract »  |  Full Text »  |  PDF »

Angiogenesis and the ischaemic heart.

R Tabibiazar and S.G Rockson (2001)
Eur. Heart J. 22, 903-918
 |  PDF »

Contribution of Bcl-2, but Not Bcl-xL and Bax, to Antiapoptotic Actions of Hepatocyte Growth Factor in Hypoxia-Conditioned Human Endothelial Cells.

K. Yamamoto, R. Morishita, S.-i. Hayashi, H. Matsushita, H. Nakagami, A. Moriguchi, K. Matsumoto, T. Nakamura, Y. Kaneda, and T. Ogihara (2001)
Hypertension 37, 1341-1348
 |  Abstract »  |  Full Text »  |  PDF »

Overexpression of FGF-2 increases cardiac myocyte viability after injury in isolated mouse hearts.

F. Sheikh, D. P. Sontag, R. R. Fandrich, E. Kardami, and P. A. Cattini (2001)
Am J Physiol Heart Circ Physiol 280, H1039-H1050
 |  Abstract »  |  Full Text »  |  PDF »

Experimental evaluation of coronary collateral development.

E. F Unger (2001)
Cardiovasc Res 49, 497-506
 |  Abstract »  |  Full Text »  |  PDF »

Therapeutic angiogenesis in cardiology using protein formulations.

M. J. Post, R. Laham, F. W. Sellke, and M. Simons (2001)
Cardiovasc Res 49, 522-531
 |  Abstract »  |  Full Text »  |  PDF »

Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a Phase I open-label dose escalation study.

R. J. Laham, N. A. Chronos, M. Pike, M. E. Leimbach, J. E. Udelson, J. D. Pearlman, R. I. Pettigrew, M. J. Whitehouse, C. Yoshizawa, and M. Simons (2000)
J. Am. Coll. Cardiol. 36, 2132-2139
 |  Abstract »  |  Full Text »  |  PDF »

Efficacy of intracoronary versus intravenous FGF-2 in a pig model of chronic myocardial ischemia.

K. Sato, R. J. Laham, J. D. Pearlman, D. Novicki, F. W. Sellke, M. Simons, and M. J. Post (2000)
Ann. Thorac. Surg. 70, 2113-2118
 |  Abstract »  |  Full Text »  |  PDF »

Therapeutic Angiogenesis With Recombinant Fibroblast Growth Factor-2 Improves Stress and Rest Myocardial Perfusion Abnormalities in Patients With Severe Symptomatic Chronic Coronary Artery Disease.

J. E. Udelson, V. Dilsizian, R. J. Laham, N. Chronos, J. Vansant, M. Blais, J. R. Galt, M. Pike, C. Yoshizawa, and M. Simons (2000)
Circulation 102, 1605-1610
 |  Abstract »  |  Full Text »  |  PDF »

Basic fibroblast growth factor in patients with intermittent claudication: results of a phase I trial.

D. F. Lazarous, E. F. Unger, S. E. Epstein, A. Stine, J. L. Arevalo, E. Y. Chew, and A. A. Quyyumi (2000)
J. Am. Coll. Cardiol. 36, 1239-1244
 |  Abstract »  |  Full Text »  |  PDF »

Basic FGF reduces stunning via a NOS2-dependent pathway in coronary-perfused mouse hearts.

T. G. Hampton, I. Amende, J. Fong, V. E. Laubach, J. Li, C. Metais, and M. Simons (2000)
Am J Physiol Heart Circ Physiol 279, H260-H268
 |  Abstract »  |  Full Text »  |  PDF »

Angiogenesis in ischemic human myocardium: clinical results after 3 years.

P. Pecher and B. A. Schumacher (2000)
Ann. Thorac. Surg. 69, 1414-1419
 |  Abstract »  |  Full Text »  |  PDF »

Role for Early Growth Response-1 Protein in alpha 1-Adrenergic Stimulation of Fibroblast Growth Factor-2 Promoter Activity in Cardiac Myocytes.

Y. Jin, F. Sheikh, K. A. Detillieux, and P. A. Cattini (2000)
Mol. Pharmacol. 57, 984-990
 |  Abstract »  |  Full Text »

Therapeutic angiogenesis with intramyocardial administration of basic fibroblast growth factor.

M. Kawasuji, H. Nagamine, M. Ikeda, N. Sakakibara, H. Takemura, S. Fujii, and Y. Watanabe (2000)
Ann. Thorac. Surg. 69, 1155-1161
 |  Abstract »  |  Full Text »  |  PDF »

Expression of vascular endothelial growth factor in patients with acute myocardial infarction.

Y. Hojo, U. Ikeda, Y. Zhu, M. Okada, S. Ueno, H. Arakawa, H. Fujikawa, T.-a. Katsuki, and K. Shimada (2000)
J. Am. Coll. Cardiol. 35, 968-973
 |  Abstract »  |  Full Text »  |  PDF »

Heparin and angiogenic therapy.

M. Fujita (2000)
Eur. Heart J. 21, 270-274
 |  PDF »

Intrapericardial Delivery of Fibroblast Growth Factor-2 Induces Neovascularization in a Porcine Model of Chronic Myocardial Ischemia.

R. J. Laham, M. Rezaee, M. Post, D. Novicki, F. W. Sellke, J. D. Pearlman, M. Simons, and D. Hung (2000)
J. Pharmacol. Exp. Ther. 292, 795-802
 |  Abstract »  |  Full Text »

Angiogenic growth factors: potential new treatment for acute myocardial infarction?.

L. M Goncalves (2000)
Cardiovasc Res 45, 294-302
 |  Abstract »  |  Full Text »  |  PDF »

Physiologically Assessed Coronary Collateral Flow and Intracoronary Growth Factor Concentrations in Patients With 1- to 3-Vessel Coronary Artery Disease.

M. Fleisch, M. Billinger, F. R. Eberli, A. R. Garachemani, B. Meier, and C. Seiler (1999)
Circulation 100, 1945-1950
 |  Abstract »  |  Full Text »  |  PDF »

Local Perivascular Delivery of Basic Fibroblast Growth Factor in Patients Undergoing Coronary Bypass Surgery : Results of a Phase I Randomized, Double-Blind, Placebo-Controlled Trial.

R. J. Laham, F. W. Sellke, E. R. Edelman, J. D. Pearlman, J. A. Ware, D. L. Brown, J. P. Gold, and M. Simons (1999)
Circulation 100, 1865-1871
 |  Abstract »  |  Full Text »  |  PDF »

Human Basic Fibroblast Growth Factor Induces Angiogenesis in Hen Eggs and Rat Hearts.

C. Seiler (1999)
Circulation 100 , 1250-1252
 |  Full Text »  |  PDF »

Transmyocardial laser revascularisation has no beneficial effect on high energy phosphates and lactate content during acute myocardial ischaemia in pigs.

O. Reuthebuch, T. Podzuweit, S. Thomas, K. Binz, M. Roth, W.-P. Klovekorn, and E. P. Bauer (1999)
Eur. J. Cardiothorac. Surg. 16, 144-149
 |  Abstract »  |  Full Text »  |  PDF »

Expression of Human Fibroblast Growth Factor 2 mRNA Is Post-transcriptionally Controlled by a Unique Destabilizing Element Present in the 3'-Untranslated Region between Alternative Polyadenylation Sites.

C. Touriol, A. Morillon, M.-C. Gensac, H. Prats, and A.-C. Prats (1999)
J. Biol. Chem. 274, 21402-21408
 |  Abstract »  |  Full Text »  |  PDF »

Bradycardia-Induced Coronary Angiogenesis Is Dependent on Vascular Endothelial Growth Factor.

W. Zheng, M. D. Brown, T. A. Brock, R. J. Bjercke, and R. J. Tomanek (1999)
Circ. Res. 85, 192-198
 |  Abstract »  |  Full Text »  |  PDF »

Multifactorial basis for coronary collateralization: a complex adaptive response to ischemia.

J. R Kersten, P. S Pagel, W. M Chilian, and D. C Warltier (1999)
Cardiovasc Res 43, 44-57
 |  Abstract »  |  Full Text »  |  PDF »

Basic Fibroblast Growth Factor Increases Regional Myocardial Blood Flow and Salvages Myocardium in the Infarct Border Zone in a Rabbit Model of Acute Myocardial Infarction.

T. Hasegawa, A. Kimura, M. Miyataka, M. Inagaki, and K. Ishikawa (1999)
Angiology 50, 487-495
 |  Abstract »  |  PDF »

Therapeutic Angiogenesis Induced by Human Recombinant Hepatocyte Growth Factor in Rabbit Hind Limb Ischemia Model as Cytokine Supplement Therapy.

R. Morishita, S. Nakamura, S.-i. Hayashi, Y. Taniyama, A. Moriguchi, T. Nagano, M. Taiji, H. Noguchi, S. Takeshita, K. Matsumoto, et al. (1999)
Hypertension 33, 1379-1384
 |  Abstract »  |  Full Text »  |  PDF »

Establishment of a Simple and Practical Procedure Applicable to Therapeutic Angiogenesis.

S. Kanno, N. Oda, M. Abe, S. Saito, K. Hori, Y. Handa, K. Tabayashi, and Y. Sato (1999)
Circulation 99, 2682-2687
 |  Abstract »  |  Full Text »  |  PDF »

Molecular advances in cardiac and cardiovascular disease.

A. Basile-Borgia, J. H Abel, and H. Mahloogi (1999)
Perfusion 14, 89-99
 |  Abstract »  |  PDF »

A New 34-Kilodalton Isoform of Human Fibroblast Growth Factor 2 Is Cap Dependently Synthesized by Using a Non-AUG Start Codon and Behaves as a Survival Factor.

E. Arnaud, C. Touriol, C. Boutonnet, M.-C. Gensac, S. Vagner, H. Prats, and A.-C. Prats (1999)
Mol. Cell. Biol. 19, 505-514
 |  Abstract »  |  Full Text »  |  PDF »

MODULATION OF MYOCARDIAL PERFUSION AND VASCULAR REACTIVITY BY PERICARDIAL BASIC FIBROBLAST GROWTH FACTOR: INSIGHT INTO ISCHEMIA-INDUCED REDUCTION IN ENDOTHELIUM-DEPENDENT VASODILATATION.

R. J. Laham, M. Simons, M. Tofukuji, D. Hung, and F. W. Sellke (1998)
J. Thorac. Cardiovasc. Surg. 116, 1022-1028
 |  Abstract »  |  Full Text »  |  PDF »

VEGF administration in chronic myocardial ischemia in pigs.

J. J Lopez, R. J. Laham, A. Stamler, J. D Pearlman, S. Bunting, A. Kaplan, J. P Carrozza, F. W Sellke, and M. Simons (1998)
Cardiovasc Res 40, 272-281
 |  Abstract »  |  Full Text »  |  PDF »

Angiogenesis and growth factor expression in a model of transmyocardial revascularization.

M. P. Pelletier, A. Giaid, S. Sivaraman, J. Dorfman, C. M. Li, A. Philip, and R. C.-J. Chiu (1998)
Ann. Thorac. Surg. 66, 12-18
 |  Abstract »  |  Full Text »  |  PDF »

Therapeutic Angiogenesis With Basic Fibroblast Growth Factor: Technique and Early Results.

F. W. Sellke, R. J. Laham, E. R. Edelman, J. D. Pearlman, and M. Simons (1998)
Ann. Thorac. Surg. 65, 1540-1544
 |  Abstract »  |  Full Text »  |  PDF »

Basic Fibroblast Growth Factor Increased Regional Myocardial Blood Flow and Limited Infarct Size of Acutely Infarcted Myocardium in Dogs.

M. Miyataka, K. Ishikawa, and R. Katori (1998)
Angiology 49, 381-390
 |  Abstract »  |  PDF »

Early Coronary Angiogenesis in Response to Thyroxine : Growth Characteristics and Upregulation of Basic Fibroblast Growth Factor.

R. J. Tomanek, M. K. Doty, and A. Sandra (1998)
Circ. Res. 82, 587-593
 |  Abstract »  |  Full Text »  |  PDF »

Induction of Neoangiogenesis in Ischemic Myocardium by Human Growth Factors : First Clinical Results of a New Treatment of Coronary Heart Disease.

B. Schumacher, P. Pecher, B. U. von Specht, and Th. Stegmann (1998)
Circulation 97, 645-650
 |  Abstract »  |  Full Text »  |  PDF »

Modulation of Growth Factor Action : Implications for the Treatment of Cardiovascular Diseases.

J. Waltenberger (1997)
Circulation 96, 4083-4094
 |  Abstract »  |  Full Text »

The Coronary Angiogenetic Effect of Heparin: Experimental Basis and Clinical Evidence.

T. Bombardini, E. Picano, and T. Bombardini (1997)
Angiology 48, 969-976
 |  Abstract »  |  PDF »

Adenovirus-Mediated Expression of the Secreted Form of Basic Fibroblast Growth Factor (FGF-2) Induces Cellular Proliferation and Angiogenesis In Vivo.

H. Ueno, J.-J. Li, S. Masuda, Z. Qi, H. Yamamoto, and A. Takeshita (1997)
Arterioscler Thromb Vasc Biol 17, 2453-2460
 |  Abstract »  |  Full Text »

Negative Inotropic Effect of Basic Fibroblast Growth Factor on Adult Rat Cardiac Myocyte.

Y. Ishibashi, Y. Urabe, H. Tsutsui, S. Kinugawa, M. Sugimachi, M. Takahashi, S. Yamamoto, H. Tagawa, K. Sunagawa, and A. Takeshita (1997)
Circulation 96, 2501-2504
 |  Abstract »  |  Full Text »

Tie2 Expression and Phosphorylation in Angiogenic and Quiescent Adult Tissues.

A. L. Wong, Z. A. Haroon, S. Werner, M. W. Dewhirst, C. S. Greenberg, and K. G. Peters (1997)
Circ. Res. 81, 567-574
 |  Abstract »  |  Full Text »

Enhanced Angiogenesis and Unfavorable Remodeling in Injured Porcine Coronary Artery Lesions: Effects of Local Basic Fibroblast Growth Factor Delivery.

M. E. Staab, R. D. Simari, S. S. Srivatsa, D. Hasdai, V. J. Pompili, D. R. Holmes, R. S. Schwartz, and R. S. Schwartz (1997)
Angiology 48, 753-760
 |  Abstract »  |  PDF »

Gene therapy for collateral vessel development.

G. Melillo, M. Scoccianti, I. Kovesdi, J. Safi Jr, T. Riccioni, and M. C Capogrossi (1997)
Cardiovasc Res 35, 480-489
 |  Abstract »  |  Full Text »  |  PDF »

Angiogenesis by gene therapy: a new horizon for myocardial revascularization?.

B. S Lewis, M. Y Flugelman, A. Weisz, I. Keren-Tal, and W. Schaper (1997)
Cardiovasc Res 35, 490-497
 |  Abstract »  |  Full Text »  |  PDF »

A role for FGF-6 in skeletal muscle regeneration.

T. Floss, H.-H. Arnold, and T. Braun (1997)
Genes & Dev. 11, 2040-2051
 |  Abstract »  |  Full Text »  |  PDF »

Basic Fibroblast Growth Factor in a Porcine Model of Chronic Myocardial Ischemia: A Comparison of Angiographic, Echocardiographic and Coronary Flow Parameters.

J. J. Lopez, E. R. Edelman, A. Stamler, M. G. Hibberd, P. Prasad, R. P. Caputo, J. P. Carrozza, P. S. Douglas, F. W. Sellke, and M. Simons (1997)
J. Pharmacol. Exp. Ther. 282, 385-390
 |  Abstract »  |  Full Text »

Manipulating Angiogenesis: From Basic Science to the Bedside.

M. S. Pepper (1997)
Arterioscler Thromb Vasc Biol 17, 605-619
 |  Abstract »  |  Full Text »

Basic Fibroblast Growth Factor as a Biochemical Marker of Exercise-Induced Ischemia.

J.-W. Gu, D. Santiago, Y. Olowe, and J. Weinberger (1997)
Circulation 95, 1165-1168
 |  Abstract »  |  Full Text »

The capillarity of left ventricular tissue of rats subjected to coronary artery occlusion.

Z. Xie, M. Gao, S. Batra, and T. Koyama (1997)
Cardiovasc Res 33, 671-676
 |  Abstract »  |  PDF »

Biological Roles of Fibroblast Growth Factor-2.

A. Bikfalvi, S. Klein, G. Pintucci, and D. B. Rifkin (1997)
Endocr. Rev. 18, 26-45
 |  Abstract »  |  Full Text »

Molecular Mechanisms of Coronary Collateral Vessel Growth.

W. Schaper and W. D. Ito (1996)
Circ. Res. 79, 911-919
 |  Full Text »

Reduction in Myocardial Infarct Size by Basic Fibroblast Growth Factor After Temporary Coronary Occlusion in a Canine Model.

M. C.G. Horrigan, A. I. MacIsaac, F. A. Nicolini, D. G. Vince, P. Lee, S. G. Ellis, and E. J. Topol (1996)
Circulation 94, 1927-1933
 |  Abstract »  |  Full Text »

Functional Upregulation of the Vascular Endothelial Growth Factor Receptor KDR by Hypoxia.

J. Waltenberger, U. Mayr, S. Pentz, and V. Hombach (1996)
Circulation 94, 1647-1654
 |  Abstract »  |  Full Text »

Elevated Basic Fibroblast Growth Factor in Pericardial Fluid of Patients With Unstable Angina.

M. Fujita, M. Ikemoto, M. Kishishita, H. Otani, R. Nohara, T. Tanaka, S.-i. Tamaki, A. Yamazato, and S. Sasayama (1996)
Circulation 94, 610-613
 |  Abstract »  |  Full Text »

Direct In Vivo Gene Transfer to Canine Myocardium Using a Replication-Deficient Adenovirus Vector.

C. J. Magovern, C. A. Mack, J. Zhang, R. T. Hahn, W. Ko, O. W. Isom, R. G. Crystal, and T. K. Rosengart (1996)
Ann. Thorac. Surg. 62, 425-433
 |  Abstract »  |  Full Text »

THE USE OF BIOLOGIC GLUE FOR BETTER ADHESIONS BETWEEN THE SKELETAL MUSCLE FLAP AND THE MYOCARDIUM AND FOR INCREASING CAPILLARY INGROWTH.

V. Chekanov, V. Nikolaychik, and G. Tchekanov (1996)
J. Thorac. Cardiovasc. Surg. 111, 678-680
 |  Full Text »

THE EFFECT OF BASIC FIBROBLAST GROWTH FACTOR ON THE BLOOD FLOW AND MORPHOLOGIC FEATURES OF A LATISSIMUS DORSI CARDIOMYOPLASTY.

J. D. Mannion, V. Blood, W. Bailey, T. L. Bauer, M. G. Magno, F. DiMeo, A. Epple, and F. G. Spinale (1996)
J. Thorac. Cardiovasc. Surg. 111, 19-28
 |  Abstract »  |  Full Text »

Basic Fibroblast Growth Factor Increases Regional Cerebral Blood Flow and Reduces Infarct Size After Experimental Ischemia in a Rat Model.

R. Tanaka, Y. Miyasaka, K. Yada, T. Ohwada, and T. Kameya (1995)
Stroke 26, 2154-2159
 |  Abstract »  |  Full Text »

Synergistic Effect of Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor on Angiogenesis In Vivo.

T. Asahara, C. Bauters, L. P. Zheng, S. Takeshita, S. Bunting, N. Ferrara, J. F. Symes, and J. M. Isner (1995)
Circulation 92, 365-371
 |  Abstract »  |  Full Text »

Potential Gene Therapy Strategies in the Treatment of Cardiovascular Disease.

R. T. Rowland, J. C. Cleveland Jr, X. Meng, A. H. Harken, and J. M. Brown (1995)
Ann. Thorac. Surg. 60, 721-728
 |  Abstract »  |  Full Text »

Arterial Gene Therapy for Therapeutic Angiogenesis in Patients With Peripheral Artery Disease.

J. M. Isner, K. Walsh, J. Symes, A. Pieczek, S. Takeshita, J. Lowry, S. Rossow, K. Rosenfield, L. Weir, E. Brogi, et al. (1995)
Circulation 91, 2687-2692
 |  Full Text »

Effects of a Single Administration of Fibroblast Growth Factor on Vascular Wall Reaction to Injury.

M. A. Parish, E. A. Grossi, F. G. Baumann, T. Asai, D. B. Rifkin, S. B. Colvin, and A. C. Galloway (1995)
Ann. Thorac. Surg. 59, 948-954
 |  Abstract »  |  Full Text »

Expression of Vascular Endothelial Growth Factor From a Defective Herpes Simplex Virus Type 1 Amplicon Vector Induces Angiogenesis in Mice.

E. A. Mesri, H. J. Federoff, and M. Brownlee (1995)
Circ. Res. 76, 161-167
 |  Abstract »  |  Full Text »

Effects of Chronic Systemic Administration of Basic Fibroblast Growth Factor on Collateral Development in the Canine Heart.

D. F. Lazarous, M. Scheinowitz, M. Shou, E. Hodge, M. A. S. Rajanayagam, S. Hunsberger, W. G. Robison Jr, J. A. Stiber, R. Correa, S. E. Epstein, et al. (1995)
Circulation 91, 145-153
 |  Abstract »  |  Full Text »

To Advertise   |   Find Products